Bifidobacterium breve UCC2003 Employs Multiple Transcriptional Regulators To Control Metabolism of Particular Human Milk Oligosaccharides

Bifidobacterial carbohydrate metabolism has been studied in considerable detail for a variety of both plant- and human-derived glycans, particularly involving the bifidobacterial prototype strain UCC2003. We recently elucidated the metabolic pathways by which the uman ilk ligosaccharide (HMO) consti...

Full description

Saved in:
Bibliographic Details
Published inApplied and environmental microbiology Vol. 84; no. 9; p. e02774-17
Main Authors James, Kieran, O'Connell Motherway, Mary, Penno, Christophe, O'Brien, Rebecca Louise, van Sinderen, Douwe
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bifidobacterial carbohydrate metabolism has been studied in considerable detail for a variety of both plant- and human-derived glycans, particularly involving the bifidobacterial prototype strain UCC2003. We recently elucidated the metabolic pathways by which the uman ilk ligosaccharide (HMO) constituents lacto- -tetraose (LNT), lacto- -neotetraose (LNnT) and lacto- -biose (LNB) are utilized by UCC2003. However, to date, no work has been carried out on the regulatory mechanisms that control the expression of the genetic loci involved in these HMO metabolic pathways. In this study, we describe the characterization of three transcriptional regulators and the corresponding operator and associated (inducible) promoter sequences, with the latter governing the transcription of the genetic elements involved in LN(n)T/LNB metabolism. The activity of these regulators is dependent on the release of specific monosaccharides, which are believed to act as allosteric effectors and which are derived from the corresponding HMOs targeted by the particular locus. Human milk oligosaccharides (HMOs) are a key factor in the development of the breastfed-infant microbiota. They function as prebiotics, selecting for a specific range of microbes, including a number of infant-associated species of bifidobacteria, which are thought to provide a range of health benefits to the infant host. While much research has been carried out on elucidating the mechanisms of HMO metabolism in infant-associated bifidobacteria, to date there is very little understanding of the transcriptional regulation of these pathways. This study reveals a multicomponent transcriptional regulation system that controls the recently identified pathways of HMO metabolism in the infant-associated prototype strain UCC2003. This not only provides insight into the regulatory mechanisms present in other infant-associated bifidobacteria but also provides an example of a network of sequential steps regulating microbial carbohydrate metabolism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation James K, O'Connell Motherway M, Penno C, O'Brien RL, van Sinderen D. 2018. Bifidobacterium breve UCC2003 employs multiple transcriptional regulators to control metabolism of particular human milk oligosaccharides. Appl Environ Microbiol 84:e02774-17. https://doi.org/10.1128/AEM.02774-17.
ISSN:0099-2240
1098-5336
DOI:10.1128/aem.02774-17